Jennifer Leohr

14PUBLICATIONS
18CO-AUTHORS
Exercise physiologyEconometric and statistical methodsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsAerodynamics (excl. hypersonic aerodynamics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Mar 26, 2026
Ultra-Rapid Lispro Has an Improved Pharmacokinetic Profile for Exercise Compared With Lispro, Resulting in Less Exercise-Associated Hypoglycemia in Adults With Type 1 Diabetes on Open-Loop Continuous Subcutaneous Insulin Infusion.

Jennifer K Leohr, Alexander Abitbol, Lauren V Turner

|Feb 23, 2026
Characterisation of steady-state pharmacokinetics and glucodynamics of once-weekly insulin efsitora alfa in individuals with type 2 diabetes.

Jennifer Leohr, Oliver Klein, Tim Heise

|Dec 04, 2025
Low immunogenicity of insulin efsitora alfa in participants with type 1 and type 2 diabetes mellitus.

Yun Wang, Sihe Wang, Wei Wang

|Jul 10, 2025
Targeting the angiopoietin-like protein 3/8 complex with a monoclonal antibody in patients with mixed hyperlipidemia: a phase 1 trial.

Daniel Gaudet, Malgorzata Gonciarz, Xi Shen

|Oct 10, 2023
Ultra rapid lispro (Lyumjev®) shortens time to recovery from hyperglycaemia compared to Humalog® in individuals with type 1 diabetes on continuous subcutaneous insulin infusion.

Jennifer Leohr, Mary Anne Dellva, Elizabeth LaBell

|Sep 05, 2023
Evaluation of postprandial total triglycerides within the TIGG model for characterizing postprandial response of glucose, insulin, and GLP-1.

Jennifer Leohr, Maria C Kjellsson

Pageof 3

Frequent Collaborators

3 joint publications

Helle Linnebjerg

3 joint publications

Eric Zijlstra

2 joint publications

Tim Heise

2 joint publications

Christoph Kapitza